Current
17.5×
5-Year Average
17.3×
All-Time High
36.7×
All-Time Low
4.3×
P/E Ratio daily chart for Elevance Health (ELV)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for Elevance Health (ELV) from 2002 to 2025
| 2025 | $77.75B | $5.66B | 13.7× | -0.3× | |
| 2024 | $83.92B | $5.98B | 14.0× | -4.3× | |
| 2023 | $109.91B | $5.99B | 18.4× | -2.4× | |
| 2022 | $122.07B | $5.89B | 20.7× | +2.3× | |
| 2021 | $112.07B | $6.10B | 18.4× | +1.1× | |
| 2020 | $78.80B | $4.57B | 17.2× | +1.3× | |
| 2019 | $76.39B | $4.81B | 15.9× | -2.1× | |
| 2018 | $67.59B | $3.75B | 18.0× | +3.0× | |
| 2017 | $57.62B | $3.84B | 15.0× | -0.4× | |
| 2016 | $37.92B | $2.47B | 15.4× | +1.1× | |
| 2015 | $36.43B | $2.56B | 14.2× | +1.2× | |
| 2014 | $33.50B | $2.57B | 13.0× | +2.6× | |
| 2013 | $26.05B | $2.49B | 10.5× | +3.5× | |
| 2012 | $18.47B | $2.66B | 7.0× | -1.3× | |
| 2011 | $21.98B | $2.65B | 8.3× | +1.0× | |
| 2010 | $20.96B | $2.89B | 7.3× | +1.8× | |
| 2009 | $25.71B | $4.75B | 5.4× | -3.0× | |
| 2008 | $20.90B | $2.49B | 8.4× | -5.9× | |
| 2007 | $47.77B | $3.35B | 14.3× | -1.3× | |
| 2006 | $48.14B | $3.09B | 15.6× | -5.6× | |
| 2005 | $52.13B | $2.46B | 21.2× | -15.5× | |
| 2004 | $35.22B | $960.10M | 36.7× | +23.3× | |
| 2003 | $10.36B | $774.30M | 13.4× | -2.5× | |
| 2002 | $8.74B | $549.10M | 15.9× | — |
- 202513.7×
- 202414.0×
- 202318.4×
- 202220.7×
- 202118.4×
- 202017.2×
- 201915.9×
- 201818.0×
- 201715.0×
- 201615.4×
- 201514.2×
- 201413.0×
- 201310.5×
- 20127.0×
- 20118.3×
- 20107.3×
- 20095.4×
- 20088.4×
- 200714.3×
- 200615.6×
- 200521.2×
- 200436.7×
- 200313.4×
- 200215.9×
About P/E Ratio at Elevance Health (ELV)
Elevance Health (ELV) P/E ratio is 17.5× as of June 5, 2026. The 5-year average is 17.3×. The sector median currently stands at 25.0×. The current ratio is at the 38th percentile of its own 10-year history.
Elevance Health (ELV) historical P/E ratio has ranged from a low of 4.3× (2010) to a high of 36.7× (2004) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
Elevance Health P/E Ratio by Year
Elevance Health P/E Ratio 2025: 13.7×
Elevance Health (ELV) P/E ratio in 2025 was 13.7×, contracted from 14.0× the prior year.
Elevance Health P/E Ratio 2024: 14.0×
Elevance Health (ELV) P/E ratio in 2024 was 14.0×, contracted from 18.4× the prior year.
Elevance Health P/E Ratio 2023: 18.4×
Elevance Health (ELV) P/E ratio in 2023 was 18.4×, contracted from 20.7× the prior year.
Elevance Health P/E Ratio 2022: 20.7×
Elevance Health (ELV) P/E ratio in 2022 was 20.7×, expanded from 18.4× the prior year.
Elevance Health P/E Ratio 2021: 18.4×
Elevance Health (ELV) P/E ratio in 2021 was 18.4×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of Elevance Health (ELV), ranked by P/E ratio.
| 23.1× | |
| 22.2× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
Elevance Health (ELV) Key Financials
Charts, filings, and peer comparison for every metric